




































































WBC 4,620 /μL TP 5.8 g/dL Glu           270  mg/dL
　Neu 55 % T-Bil 0.3 mg/dL HbA1c 8.7 %
　Ly 36 % ALP 657 U/L TG 254 mg/dL
　Mo 6 % γ-GTP 11 U/L T-cho 115 mg/dL
　Ba 0 % LDH 166 U/L
　Eo 0.5 % Alb 3.4 g/dL 電解質
RBC 150万 /μL ALT 3 U/L Na 136 mmol/L
Hb 4.3 g/dL AST 6 U/L K 5.8 mmol/L
Ht 38.2 % Cre 1.75 mg/dL Cl 105 mmol/L
Retic 0.2 % UN 51 mg/dL IP 1.7 mg/dL
MCV 94 fL UA 5 mg/dL 補正 Ca 8.4 mg/dL
MCH 28.7 pg CRP 0.34 mg/dL Mg 2.6 mg/dL
Fe 204 μg/dL
Plt 9.6万 /μL TIBC 220 μg/dL
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13廣瀬，他：臍帯血移植後のヒトパルボウイルス B19 による赤芽球癆
Red-cell aplasia due to persistent human parvovirus B19 infection three  
years after umbilical cord blood transplantation-a case study
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ABSTRACT   Onset of anemia after hematopoietic stem cell transplantation can be caused 
by various background factors such as reduced hematopoiesis of the bone marrow and viral 
infection. Therefore, diagnosis is often difficult. Human parvovirus B19 (PVB19) due to acquired 
pure red-cell aplasia is the causative virus of erythema infectiosum, and it is well known 
that patients with hemolytic anemia with a short erythrocyte life span such as in the case of 
hereditary spherocytosis present with acute red-cell aplasia. PVB19 can cause chronic anemia 
in immunocompromised patients, including transplantation patients, and while there are many 
reported cases in kidney transplant patients, etc., there are few reported cases of cord blood 
transplantation. Here, we report a case of onset of PVB19 that occurred three years after 
successful umbilical cord blood transplantation and caused persistent infection for over a 
period of four months. (Accepted on October 30, 2019)
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